← All companies

IMDX

Insight Molecular Diagnostics Inc.

IMDX Nasdaq In Vitro & In Vivo Diagnostic Substances EDGAR ↗

$5.12

+0.00 0.00%

Key statistics

from XBRL data in SEC filings

Market cap

$165M

Revenue (TTM)

$1.95M

Net income (TTM)

$2.33M

EPS (TTM)

$-1.51

P/E ratio

—

Dividend yield

1875000.00%

Free cash flow

-$25.4M

Cash

$28.2M

Total assets

$40.4M

Gross margin

50.7%

52-week range

$2.33 – $8.51

Recent SEC filings

40 most recent

Annual, quarterly & current reports

8-K Director or officer change; Shareholder vote results Jun 17, 2026 10-Q Quarter ended 2026-03-31 May 13, 2026 8-K Results of operations (earnings release) May 13, 2026 8-K/A Other events May 13, 2026 8-K Other events Apr 30, 2026 10-K Fiscal year ended 2025-12-31 Mar 26, 2026 8-K Results of operations (earnings release) Mar 26, 2026 8-K Entered a material agreement Feb 26, 2026 8-K Entered a material agreement; Other events Feb 12, 2026 8-K Regulation FD disclosure Feb 11, 2026 10-Q Quarter ended 2025-09-30 Nov 10, 2025 8-K Results of operations (earnings release) Nov 10, 2025 8-K Director or officer change Oct 2, 2025 8-K Director or officer change Sep 19, 2025 10-Q Quarter ended 2025-06-30 Aug 11, 2025 8-K Results of operations (earnings release) Aug 11, 2025 8-K Shareholder vote results Jul 2, 2025 8-K Amended charter or bylaws; Regulation FD disclosure Jun 17, 2025 10-Q Quarter ended 2025-03-31 May 12, 2025 8-K Results of operations (earnings release) May 12, 2025 8-K Changed accountants Apr 17, 2025 10-K Fiscal year ended 2024-12-31 Mar 24, 2025 8-K Results of operations (earnings release) Mar 24, 2025 8-K Director or officer change Mar 10, 2025 8-K Entered a material agreement; Terminated a material agreement; Unregistered sale of equity; Regulation FD disclosure Feb 10, 2025 8-K Entered a material agreement Jan 8, 2025 10-Q Quarter ended 2024-09-30 Nov 12, 2024 8-K Results of operations (earnings release) Nov 12, 2024 8-K Director or officer change; Shareholder vote results Oct 15, 2024 8-K Entered a material agreement; Unregistered sale of equity; Regulation FD disclosure; Other events Oct 3, 2024 8-K Entered a material agreement; Terminated a material agreement Aug 9, 2024 10-Q Quarter ended 2024-06-30 Aug 8, 2024 8-K Results of operations (earnings release) Aug 8, 2024 8-K Delisting notice or listing-rule failure Jul 12, 2024 8-K Shareholder vote results; Other events Jul 5, 2024 8-K Director or officer change Jun 17, 2024 8-K Director or officer change May 31, 2024 8-K Director or officer change May 23, 2024 8-K Results of operations (earnings release) May 15, 2024 10-Q Quarter ended 2024-03-31 May 15, 2024